Membranous Nephropathy
📧 Sign up to get email alerts when something new happens for Membranous Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) [Phase 2, Phase 3]
Clinical trial update for povetacicept in primary membranous nephropathy, currently recruiting in Phase 2/3 to evaluate efficacy, safety, an…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) [Phase 3]
A Phase 3 clinical trial is evaluating felzartamab infusions in adults with primary membranous nephropathy, and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases [EARLY_Phase 1]
An early Phase 1 clinical study evaluating the safety and efficacy of GT719 universal cell injection for immune-mediated kidney diseases is …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating Budoprutug for primary membranous nephropathy is currently recruiting, sponsored by Climb Bio, Inc.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of finerenone in patients with primary membranous nephropathy is currently recru…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy [Phase 3]
A Phase 3 clinical trial evaluating obinutuzumab for primary membranous nephropathy is underway and currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of WAL0921 in Patients With Glomerular Kidney Diseases [Phase 2]
Walden Biosciences reports a Phase 2 clinical trial of WAL0921 in multiple glomerular diseases, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy [NA]
A completed clinical trial evaluating the role of the anti-mouse PLA2R1 ELISA in membranous nephropathy.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: An Outcome Analysis of Primary Membranous Nephropathy
Clinical trial update detailing an outcome analysis for primary membranous nephropathy; the study is currently recruiting and sponsored by t…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Autoreactive B Cells in Membranous Nephropathy
A clinical trial is investigating autoreactive B cells in membranous nephropathy and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) [Phase 1, Phase 2]
Nkarta, Inc. is conducting a Phase 1/2 study of NKX019 for autoimmune diseases and is currently recruiting. The trial targets lupus nephriti…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating zanubrutinib for adults with primary membranous nephropathy to assess its efficacy and safety; the …
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Omics of Rituximab-resistance
A clinical trial update describes an omics study investigating Rituximab resistance in membranous nephropathy, sponsored by Mario Negri Inst…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: NEPTUNE Match Study [NA]
The NEPTUNE Match Study is currently recruiting, focusing on nephrotic syndrome in children and related glomerular diseases such as focal se…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Belimumab With Rituximab for Primary Membranous Nephropathy [Phase 2]
Phase 2 clinical trial evaluating the combination of belimumab with rituximab for primary membranous nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Phase I Study of YK012 in Primary Membranous Nephropathy [Phase 1]
Phase I clinical trial of YK012 for primary membranous nephropathy; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy [Phase 2]
A Phase 2 randomized, open-label, multicenter trial evaluating SHR-2173 for primary membranous nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study) [Phase 3]
Phase 3 Blossom Study comparing Obinutuzumab against cyclophosphamide plus glucocorticoids for primary membranous nephropathy is currently r…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Atacicept in Multiple Glomerular Diseases [Phase 2]
Phase 2 clinical trial evaluating atacicept in multiple glomerular diseases is currently recruiting, including primary membranous nephropath…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study [Phase 2, Phase 3]
A pilot Phase 2/3 clinical trial is evaluating obinutuzumab for membranous nephropathy with PLA2R antibody decreases, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
This clinical trial update describes an interview study of adult and pediatric patients with swelling due to nephrotic syndrome and of paren…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy [Phase 2]
A Phase II study evaluating Zuberitamab injection in patients with primary membranous nephropathy is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis [Phase 2]
Phase 2 trial evaluating HLX79 in combination with Rituximab versus placebo for active glomerulonephritis, including membranous nephropathy …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Study of YK012 in Primary Membranous Nephropathy [Phase 1]
A Phase 1 clinical trial evaluating YK012 in primary membranous nephropathy is currently recruiting. The sponsor is Excyte Biopharma Ltd.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases [Phase 1, Phase 2]
An open-label Phase 1/2 study evaluating povetacicept in autoantibody-associated glomerular diseases is active but not recruiting.